Ozempic Ozempic is a GLP-1 receptor agonist originally approved to help manage type 2 diabetes
Rapamycin has been extensively studied for immunomodulatory effects across autoimmune diseases
Ursolic acid nano-liposomes, as a chemotherapy nanomedicine, delivers ursolic acid through nano-liposomal injection and has already undergone clinical trials in China in 2023 (CTR20230593)
Apolipoprotein B synthesis inhibition with mipomersen in heterozygous familial hypercholesterolemia: results of a randomized, double-blind, placebo-controlled trial to assess efficacy and safety as add-on therapy in patients with coronary artery disease
A long action profile supports a single weekly subcutaneous injection , and a stepwise dose increase helps keep tolerability high while the body adjusts [3] [4]
Research suggests that GHK-Cu may play a potentially key role in restoring damaged tissues, wound repair, and supporting immune response